DARAPRIM Side Effects

DARAPRIM Safety Questions, DARAPRIM Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about DARAPRIM. Our extensive database of DARAPRIM adverse events and DARAPRIM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about DARAPRIM

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




DARAPRIM Safety Reports

Total DARAPRIM reports: 12.
DARAPRIM FDA safety alerts: No.
Reported deaths: 1    Reported hospitalizations: 1.
Take DARAPRIM Side Effects Survey or Share Your DARAPRIM Story. DARAPRIM Usage.

Physician from GERMANY reported DARAPRIM problem on Jan 16, 2007. Female patient, 19 years of age, was diagnosed with toxoplasmosis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: alopecia, blood disorder, nervous system disorder, skin hyperpigmentation, tongue ulceration. DARAPRIM dosage: unknown. During the same period patient was treated with SULFADIAZIN. Patient recovered.

DARAPRIM problem was reported by a Physician from GERMANY on Jan 24, 2007. Female patient, 19 years of age, weighting 163.1 lb, was diagnosed with toxoplasmosis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: alopecia, blood disorder, nervous system disorder, pruritus, skin hyperpigmentation, tongue ulceration. DARAPRIM dosage: 25MG TWICE PER DAY. During the same period patient was treated with SULFADIAZIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DARAPRIM problem on Mar 12, 2007. Female patient, 87 years of age, was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: kidney infection, nephrolithiasis. DARAPRIM dosage: unknown. Patient recovered.

DARAPRIM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient, 87 years of age, was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: kidney infection, nephrolithiasis. DARAPRIM dosage: unknown. During the same period patient was treated with DYAZIDE. Patient recovered.

Physician from GERMANY reported DARAPRIM problem on Apr 23, 2007. Female patient, 30 years of age, was diagnosed with toxoplasmosis, prophylaxis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: anaemia, leukopenia, rash, thrombocytopenia. DARAPRIM dosage: 25MG PER DAY. During the same period patient was treated with SULFADIAZINE, FOLIC ACID. Patient recovered.

DARAPRIM problem was reported by a Health Professional from GERMANY on July 05, 2006. Male patient, weighting 8.60 lb, was diagnosed with congenital toxoplasmosis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. DARAPRIM dosage: 3MG PER DAY. Patient recovered.

Physician from GERMANY reported DARAPRIM problem on July 14, 2006. Female patient was diagnosed with eye infection toxoplasmal and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dermatitis allergic, dizziness, eye infection toxoplasmal, eyelid oedema, laryngeal oedema, vertigo. DARAPRIM dosage: 25 MG / PER DAY /. During the same period patient was treated with MEPRON, SULFADIAZINE, PREDNISONE, CLINDAMYCIN. Patient recovered.

DARAPRIM problem was reported by a Health Professional from GERMANY on July 05, 2006. Male patient, weighting 8.60 lb, was diagnosed with congenital toxoplasmosis, neonatal infection and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. DARAPRIM dosage: 3MG PER DAY. During the same period patient was treated with AMPICILLIN, SULFADIAZIN, LEDERFOLAT. Patient was hospitalized. Patient recovered.

Physician from GERMANY reported DARAPRIM problem on Sept 01, 2006. Female patient, 18 years of age, was diagnosed with toxoplasmosis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, erythropenia, headache, leukopenia, nausea, thrombocytopenia, vomiting. DARAPRIM dosage: 25MG TWICE PER DAY. During the same period patient was treated with SULFADIAZIN. Patient recovered.

DARAPRIM problem was reported by a Physician from GERMANY on July 16, 2007. Female patient, 30 years of age, was diagnosed with toxoplasmosis, prophylaxis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: anaemia, delivery, leukopenia, rash, thrombocytopenia. DARAPRIM dosage: 25MG PER DAY. During the same period patient was treated with SULFADIAZINE, FOLIC ACID. Patient recovered.

Consumer or non-health professional from SINGAPORE reported DARAPRIM problem on Aug 01, 2007. Female patient was diagnosed with toxoplasmosis and was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: bleeding time abnormal, nausea, petechiae, platelet count decreased, platelet function test abnormal, thrombocytopenia. DARAPRIM dosage: 25MG TWICE PER DAY. Patient recovered.

DARAPRIM problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2007. Female patient, 87 years of age, was treated with DARAPRIM. After drug was administered, patient experienced the following problems/side effects: kidney infection, nephrolithiasis. DARAPRIM dosage: unknown. During the same period patient was treated with DYAZIDE. Patient died.

Ask Our Patient Community about DARAPRIM

>>New! Check out useful Hospital Quality Data! Click on a state to continue:

ALABAMA
ALASKA
AMERICAN SAMOA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
DISTRICT OF COLUMBIA
FEDERATED STATES OF MICRONESIA
FLORIDA
GEORGIA
GUAM
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARSHALL ISLANDS
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
MONTANA
NEBRASKA
NEVADA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEW YORK
NORTH CAROLINA
NORTH DAKOTA
NORTHERN MARIANA ISLANDS
OHIO
OKLAHOMA
OREGON
PALAU
PENNSYLVANIA
PUERTO RICO
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VERMONT
VIRGIN ISLANDS
VIRGINIA
WASHINGTON
WEST VIRGINIA
WISCONSIN
WYOMING

>>NEW! Home Care Provider Quality Reports and Home Care Provider Reviews

ALABAMA
ALASKA
AMERICAN SAMOA
ARIZONA
ARKANSAS
CALIFORNIA
COLORADO
CONNECTICUT
DELAWARE
DISTRICT OF COLUMBIA
FEDERATED STATES OF MICRONESIA
FLORIDA
GEORGIA
GUAM
HAWAII
IDAHO
ILLINOIS
INDIANA
IOWA
KANSAS
KENTUCKY
LOUISIANA
MAINE
MARSHALL ISLANDS
MARYLAND
MASSACHUSETTS
MICHIGAN
MINNESOTA
MISSISSIPPI
MISSOURI
MONTANA
NEBRASKA
NEVADA
NEW HAMPSHIRE
NEW JERSEY
NEW MEXICO
NEW YORK
NORTH CAROLINA
NORTH DAKOTA
NORTHERN MARIANA ISLANDS
OHIO
OKLAHOMA
OREGON
PALAU
PENNSYLVANIA
PUERTO RICO
RHODE ISLAND
SOUTH CAROLINA
SOUTH DAKOTA
TENNESSEE
TEXAS
UTAH
VERMONT
VIRGIN ISLANDS
VIRGINIA
WASHINGTON
WEST VIRGINIA
WISCONSIN
WYOMING
PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about prescription drug side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding DARAPRIM safety information and found answers to Your Questions about DARAPRIM side effects